Tislelizumab Combined With Chemotherapy Followed by Thoracic Consolidation Radiotherapy in the First-line Treatment of Extensive Stage Small Cell Lung Cancer

NCT07425795 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

36

Enrollment

OTHER

Sponsor class

Conditions

Extensive Stage Small Cell Lung Cancer (ES-SCLC)

Interventions

DRUG: Tislelizumab Combined With Chemotherapy

Sponsor

Chongqing University Cancer Hospital